Biocon LimitedNSE: BIOCON

Press Release Dec 07 2021

· Issued by Biocon Limited

Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated December 07, 2021, titled "Biocon Ltd partners with Tabuk Pharmaceuticals to commercialise its speciality generic medicines in the Middle East".

View Attachment

6ix hasn’t read this filing yet.

Biocon Limited on 6ix

Earlier from Biocon

Later from Biocon

All Biocon news releases